Beigene Ltd Corporate Update: Global Strategic Oncology Collaboration with Amgen Transcript
Hello and welcome to the call to discuss the global strategic collaboration between BeiGene and Amgen. My name is Jeff, and I will be your conference call coordinator. There will be a question-and-answer session after the prepared remarks.
I would now like to introduce your host for today's conference, Dr. Howard Liang, Chief Financial Officer. Dr. Liang, you may begin.
Thank you very much, Jeff, and a warm welcome to all of you joining us from around the world, early morning in Asia and especially those in the U.S. on this Halloween night. On today's call, we'll discuss our exciting global strategic collaboration with Amgen that we announced early today in a press release. We also filed an 8-K with the SEC that provide additional details of the transaction.
On this call, we'll be presenting slides to those following us on the webcast, which can be accessed at ir.beigene.com.
Our CEO, John Oyler, will start us off with an overview of the -- with the strategic rationale
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
